Sensus Healthcare, Inc. (SRTS) News
Filter SRTS News Items
SRTS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SRTS News Highlights
- SRTS's 30 day story count now stands at 10.
- Over the past 18 days, the trend for SRTS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- APTX, BEAT and ESEA are the most mentioned tickers in articles about SRTS.
Latest SRTS News From Around the Web
Below are the latest news stories about Sensus Healthcare Inc that investors may wish to consider to help them evaluate SRTS as an investment opportunity.
Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be SustainableIf you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. |
Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue EstimatesSensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? |
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for oncological and non-oncological conditions, announces financ |
VeriSign (VRSN) to Report Q4 Earnings: What's in Store?Higher .com and .net domain name registrations supported by a recovering global economy might have aided VeriSign's (VRSN) performance in the fourth quarter of 2021. |
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Zacks.com featured highlights include: Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, IncSensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc are highlighted in this Screen of the Week article. |
Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)Sensus Healthcare, Inc. (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. |
Buy These 4 Low-Beta Stocks to Sail Through the Choppy MarketIt is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd. (ESEA) and Vocera (VCRA) are well poised to gain. |
Sensus Healthcare Prepares Organization for Long-term Growth with Three PromotionsMichael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of SalesBOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General Counsel Michael J. Sardano has been promoted to President and Gene |
Is Aptinyx Inc. (APTX) Outperforming Other Medical Stocks This Year?Here is how Aptinyx Inc. (APTX) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year. |